First-Episode of Synthetic Cannabinoid-InducedPsychosis in a Young Adult, Successfully Managed withHospitalization and Risperidone

Synthetic cannabinoids- (SCs-) induced psychosis is a growing public health concern. It leads to significant impairment, includingemotional distress, difficulty communicating, and other debilitating symptoms. In this case report, we discuss a patient with noprevious history of psychotic symptoms, presenting with first-episode psychosis in the context of progressive, acutely worsening,disorganized, psychotic thoughts and behaviors following prolonged use of SCs. We also discuss relevant literature on SCs-inducedpsychosis, highlighting its prevalence, presentation, diagnosis, and recommended management. It is important to diagnose and treatSCs-induced psychosis as early and efficiently as possible, in order to alleviate symptoms while limiting functional impairment andemotional distress to the patient.